Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma

STIE cells are significant for treatment response, can be reshaped differentially after TACE, SBRT, and IO. The most significant changes of T-lymphocyte lineage are SBRT associated modulations in CD25<sup>+</sup>CD8<sup>+</sup> T cells, CD127<sup>+</sup>CD8<sup>+</sup> T cells, and NKT cells, which also have significant effects on the ultimate treatment response after TACE-SBRT-IO (ClinicalTrails.gov identifier: GCOG0001/NCT05061342).

Authors

Institutions

Publication Details

Journal
Journal of the National Cancer Center
Published
2024-11-28
DOI
https://doi.org/10.1016/j.jncc.2024.06.007
Citations
6
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
2.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma

Danyang Zheng, Chung Mau Lo, Wan-Hang Keith Chiu, Chi‐Leung Chiang et al.
6 citations
Journal of the National Cancer Center
Hepatocellular Carcinoma Treatment and Prognosis
2.22
article

Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma

Danyang Zheng, Chung Mau Lo, Wan-Hang Keith Chiu, Chi‐Leung Chiang, Ji Ren, Carmen W.H. Chan, Feng‐Ming Kong, C. Li, Weiwei Chen, Cai‐Ning Zhao, Wenqi Chen, Salma K. Jabbour, Sik-Kwan Chan
article en
6 citations

Abstract

STIE cells are significant for treatment response, can be reshaped differentially after TACE, SBRT, and IO. The most significant changes of T-lymphocyte lineage are SBRT associated modulations in CD25<sup>+</sup>CD8<sup>+</sup> T cells, CD127<sup>+</sup>CD8<sup>+</sup> T cells, and NKT cells, which also have significant effects on the ultimate treatment response after TACE-SBRT-IO (ClinicalTrails.gov identifier: GCOG0001/NCT05061342).

Journal of the National Cancer CenterVol. 5(1)
Chinese University of Hong Kong (HK), Chinese Academy of Sciences (CN), University of Hong Kong - Shenzhen Hospital (CN), Shenzhen Institutes of Advanced Technology (CN), Queen Elizabeth Hospital (CN), University of Hong Kong (HK)
University of Hong Kong, Hong Kong Polytechnic University, Science, Technology and Innovation Commission of Shenzhen Municipality, Shenzhen Fundamental Research Program
Good health and well-being
Openalex Percentile: Top 11%
Hepatocellular Carcinoma Treatment and Prognosis
2.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.